Elevation of CSF adenosine deaminase in HIV patient with meningitis from retroviral rebound syndrome, a case report

Int J Infect Dis. 2020 Sep:98:297-298. doi: 10.1016/j.ijid.2020.06.050. Epub 2020 Jun 17.

Abstract

Adenosine deaminase (ADA) in cerebrospinal fluid (CSF) is considered to be a useful biomarker in differentiating tuberculous meningitis (TBM) from other meningitis in non-HIV patients. However, its specificity decreases in patients with HIV, and other diseases such as cytomegalovirus encephalitis, toxoplasmosis or meningeal lymphomatosis can also elevate ADA in CSF. We here report a rare case of retroviral rebound syndrome in a HIV patient, whose ADA in CSF was elevated.

Keywords: Adenosine deaminase; Cerebrospinal fluid; Human immunodeficiency virus; Meningitis; Retroviral rebound syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Deaminase / cerebrospinal fluid*
  • Adult
  • Biomarkers / cerebrospinal fluid
  • HIV Infections / cerebrospinal fluid
  • HIV Infections / complications*
  • Humans
  • Male
  • Tuberculosis, Meningeal / cerebrospinal fluid
  • Tuberculosis, Meningeal / diagnosis*
  • Tuberculosis, Meningeal / enzymology*
  • Tuberculosis, Meningeal / etiology

Substances

  • Biomarkers
  • Adenosine Deaminase